Algorae Pharmaceuticals Ltd
ASX:1AI
Algorae Pharmaceuticals Ltd
ASX:1AI
Price:
0.0085
AUD
6.25%
Market Cap:
AU$17.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Algorae Pharmaceuticals Ltd
ASX:1AI
|
AU |
|
S
|
Service Corporation International
SWB:SVC
|
US |
|
D
|
Dampskibsselskabet Norden A/S
DUS:D69
|
DK |
|
M
|
Matching Maximize Solution PCL
SET:MATCH
|
TH |
|
Krungthai Card PCL
OTC:KGTHY
|
TH |
|
J
|
Johan Holdings Bhd
KLSE:JOHAN
|
MY |
|
Oppenheimer Holdings Inc
NYSE:OPY
|
US |
|
J
|
Jost AG
SWB:JOX
|
DE |
|
G
|
Galan Lithium Ltd
F:9CH
|
AU |
|
C
|
Canadian GoldCamps Corp
F:A68
|
CA |
|
P
|
Pandora A/S
XMUN:3P7
|
DK |
|
FBD Holdings PLC
F:EG7
|
IE |
|
Falmaco Nonwoven Industri Tbk PT
IDX:FLMC
|
ID |
|
T
|
TDK Corp
F:TDK
|
JP |
Intrinsic Value
Not Available for 1AI
There is not enough data to reliably calculate the intrinsic value for Algorae Pharmaceuticals Ltd.
Do our valuations actually work? See backtest results .
Alternatives to 1AI
Fundamental Analysis
What Algorae Pharmaceuticals Does
Algorae Pharmaceuticals Ltd is a small Australian drug-development company that uses artificial intelligence to help find and design new medicines. It does not sell finished drugs today; instead, it works on early-stage pharmaceutical research and builds a pipeline of candidate treatments that may later be licensed or developed further with partners.
- Headquarters
- Australia AU
- IPO date
- Sep 1, 2004
Financials
Efficiency
Earnings Waterfall
Algorae Pharmaceuticals Ltd
Algorae Pharmaceuticals Ltd
